Searched for
OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION USP
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- In 1860, German chemistry PhD Albert Niemann isolated cocaine from coca leaves; the tongue-numbness he noted led to the first local anesthesia 24 years laterA simple observation of numbness from coca leaves led to a medical revolution. Scientists isolated cocaine, revealing its power to block pa...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Dr Reddy's Laboratories Q3 Results: Profit falls 14% YoY to Rs 1,210 crore, revenue up 4%Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margin...
- Dr Reddy's launches generic OTC ophthalmic solution in US marketDr Reddy's Laboratories has launched a new eye drop in the United States. This over-the-counter solution treats itchy eyes. It is an antihi...
- Glenmark launches generic glaucoma treatment ophthalmic solutionGlenmark Pharmaceuticals Inc., USA launched a generic version of Travatan Z, a glaucoma treatment, called Travoprost ophthalmic solution (0...
- Suspended eye drops not intended to replace glasses, says Entod CEOMumbai-based Entod Pharmaceuticals clarified that its eye drop PresVu is not intended to replace reading glasses for presbyopia. This follo...
- DCGI suspends permission to Entod pharma's eye drop, company to challenge order in courtThe DCGI has suspended Entod Pharmaceuticals' permission to manufacture and sell eye drops claimed to reduce dependency on reading glasses ...
- Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...
- Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...
- Caplin Point jumps 6% on USFDA nod for local anesthesiaThis is a generic therapeutic equivalent version of NAROPIN Injection, of Fresenius Kabi USA LLC.
- Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...
- Lupin launches generic conjunctivitis treatment medicine in USThe product is produced at Lupin's Pithampur manufacturing facility, it added. The medicine is generic equivalent of Novartis Corp's Vigamo...
- Aurobindo Pharma gets USFDA nod for its conjunctivitis drugAurobindo Pharma has received approval from the USFDA nod for generic Olopatadine Hydrochloride ophthalmic solution used for treatment of c...
- Wockhardt gets USFDA nod for generic eye dropsDrug maker Wockhardt said it has received tentative approval from the US health regulator to market Olopatadine hydrochloride eye drops in ...
- Wockhardt receives USFDA approval for generic eye dropsDrug maker Wockhardt today said it has received tentative approval from the US health regulator.
Load More
